The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy
- 31 January 2022
- journal article
- research article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 22 (4) , 359-366
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Impact of the Length of Vitamin D Deficiency on Cardiac RemodelingCirculation: Heart Failure, 2013
- Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated ratsClinical and Experimental Medicine, 2011
- Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatmentEndocrine-Related Cancer, 2010
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cellsOncogene, 2009
- Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptorBiological Chemistry, 2008
- Inhibition of p38 by Vitamin D Reduces Interleukin-6 Production in Normal Prostate Cells via Mitogen-Activated Protein Kinase Phosphatase 5: Implications for Prostate Cancer Prevention by Vitamin DCancer Research, 2006
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Anthracycline-induced cardiomyopathySeminars in Oncology, 2001
- Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Diagnostic value of serum creatine kinase and lactate dehydrogenase isoenzyme determinations for monitoring early cardiac damage in ratsToxicology Letters, 1988